[Skip to Content]
[Skip to Content Landing]
Letters
May 14, 2003

Cost-effectiveness of Screening for Lung Cancer—Reply

JAMA. 2003;289(18):2357. doi:10.1001/jama.289.18.2357-a

To the Editor: Dr Mahadevia and colleagues1 concluded that helical computed tomography (CT) should not be used as a screening tool for lung cancer. They based their conclusion on the results of their cost-effectiveness analysis, which relied on several assumptions about the costs and benefits of helical CT screening. I believe that these assumptions were overly optimistic, however, and that helical CT is thus probably even less effective than the authors conclude.

×